An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-16
DOI
10.1038/s41467-021-25197-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination
- (2020) Xiaobo Xi et al. Science Advances
- Albumin-biomineralized nanoparticles to synergize phototherapy and immunotherapy against melanoma
- (2020) Yining Zhu et al. JOURNAL OF CONTROLLED RELEASE
- Proton-driven transformable nanovaccine for cancer immunotherapy
- (2020) Ningqiang Gong et al. Nature Nanotechnology
- A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
- (2020) Lin Qin et al. Science Advances
- Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity
- (2019) D. Scott Wilson et al. NATURE MATERIALS
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia
- (2019) Jincheng Yang et al. INVESTIGATIONAL NEW DRUGS
- Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
- (2019) Lv Chen et al. ADVANCED MATERIALS
- Light-Triggered Retention and Cascaded Therapy of Albumin-Based Theranostic Nanomedicines to Alleviate Tumor Adaptive Treatment Tolerance
- (2018) Jing Chen et al. ADVANCED FUNCTIONAL MATERIALS
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination
- (2018) Yufei Xia et al. NATURE MATERIALS
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands
- (2018) Zhikuan Zhang et al. Cell Reports
- Self-Healing, Self-Assembled β-Sheet Peptide–Poly(γ-glutamic acid) Hybrid Hydrogels
- (2017) David E. Clarke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
- (2017) Carlene Petes et al. Frontiers in Immunology
- Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy
- (2016) Liangzhu Feng et al. ACS Nano
- An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome
- (2016) Lin Kang et al. Acta Biomaterialia
- Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy
- (2016) Chenggen Qian et al. ADVANCED MATERIALS
- In situ vaccine production and delivery
- (2016) P. Yeagle SCIENCE
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- (2015) P. H. Lizotte et al. Nature Nanotechnology
- Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance
- (2015) Tuo Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptive Amphiphilic Dendrimer-Based Nanoassemblies as Robust and Versatile siRNA Delivery Systems
- (2014) Xiaoxuan Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
- (2013) A. de Titta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Amphiphilic Dendrimer for Effective Delivery of Small Interfering RNA and Gene Silencing In Vitro and In Vivo
- (2012) Tianzhu Yu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Current adjuvants and new perspectives in vaccine formulation
- (2011) Emanuele Montomoli et al. Expert Review of Vaccines
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search